{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T13:39:19Z","timestamp":1772804359153,"version":"3.50.1"},"reference-count":14,"publisher":"Cambridge University Press (CUP)","issue":"6","license":[{"start":{"date-parts":[[2007,8,3]],"date-time":"2007-08-03T00:00:00Z","timestamp":1186099200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epidemiol. Infect."],"published-print":{"date-parts":[[2008,6]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>This study evaluated the first use of a combination of the lyophilized components of the conjugated group C vaccine Menjugate\u2122 reconstituted with the liquid group B outer membrane vesicle (OMV) vaccine MeNZB\u2122. At 6-week intervals, healthy residential students received three doses of MeNZB alone or concomitantly with one dose of Menjugate (MeNZB+MenC). Short-lasting injection-site reactions of mild or moderate intensity were frequent in both groups. There were no vaccine-related serious adverse events. After three doses, the percentage of subjects with serum bactericidal assay (SBA) titres \u2a7e1:8 against the serogroup B strain NZ98\/254 was 82% for MeNZB+MenC and 78% for MeNZB. All subjects in the MeNZB+MenC group achieved SBA titres \u2a7e1:8 against serogroup strain C11 and 67% in the MeNZB group. All SBA and ELISA responses of the combined vaccine were at least as good as for MeNZB alone. After vaccination, the pharyngeal carriage rate of any meningococcus in the vaccinated group had declined from 40% to 21%.<\/jats:p>","DOI":"10.1017\/s0950268807009211","type":"journal-article","created":{"date-parts":[[2007,8,3]],"date-time":"2007-08-03T12:35:27Z","timestamp":1186144527000},"page":"790-799","source":"Crossref","is-referenced-by-count":12,"title":["Combined administration of serogroup B meningococcal vaccine and conjugated serogroup C meningococcal vaccine is safe and immunogenic in college students"],"prefix":"10.1017","volume":"136","author":[{"given":"J.\u00a0D.","family":"HOLMES","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"MARTIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"RAMSAY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"YPMA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"OSTER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2007,8,3]]},"reference":[{"key":"S0950268807009211_ref011","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.01.070"},{"key":"S0950268807009211_ref001","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.01.050"},{"key":"S0950268807009211_ref003","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.01.063"},{"key":"S0950268807009211_ref006","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1128\/JCM.33.12.3133-3137.1995","article-title":"Meningococcal carriage, alcohol consumption, and campus bar patronage in a serogroup C meningococcal disease outbreak","volume":"33","author":"Imrey","year":"1995","journal-title":"Journal of Clinical Microbiology"},{"key":"S0950268807009211_ref002","unstructured":"2.\u00a0 Martin D , McDowell R . The Epidemiology of Meningococcal Disease in New Zealand in 2003. Report prepared for the Ministry of Health by the Institute of Environmental Science and Research Limited (ESR). Wellington: Ministry of Health, 2004 (http:\/\/www.moh.govt.nz\/moh.nsf\/0\/C088F437895D6DC8CC256ED1000B2539\/$File\/epidemiologyofmeningococcaldisease2003.pdf). Accessed 3 July 2007."},{"key":"S0950268807009211_ref012","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1128\/CDLI.8.3.616-623.2001","article-title":"Importance of complement source in measuring meningococcal bactericidal titres","volume":"8","author":"Santos","year":"2001","journal-title":"Clinical and Diagnostic Laboratory Immunology"},{"key":"S0950268807009211_ref008","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1128\/JCM.32.2.323-330.1994","article-title":"Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population","volume":"32","author":"Caugant","year":"1994","journal-title":"Journal of Clinical Microbiology"},{"key":"S0950268807009211_ref007","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.6.688"},{"key":"S0950268807009211_ref010","doi-asserted-by":"publisher","DOI":"10.1086\/513768"},{"key":"S0950268807009211_ref013","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/CDLI.4.2.156-167.1997","article-title":"Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays","volume":"4","author":"Maslanka","year":"1997","journal-title":"Clinical and Diagnostic Laboratory Immunology"},{"key":"S0950268807009211_ref004","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1128\/CDLI.12.5.599-605.2005","article-title":"Combined administration of meningococcal serogroup B outer membrane vesicle vaccine and conjugated serogroup C vaccine indicated for prevention of meningococcal disease is safe and immunogenic","volume":"12","author":"Aaberge","year":"2005","journal-title":"Clinical and Diagnostic Laboratory Immunology"},{"key":"S0950268807009211_ref014","first-page":"793","article-title":"Progress in enzyme immunoassays: production of reagents, experimental design, and interpretation","volume":"63","author":"Kurstak","year":"1985","journal-title":"Bulletin of the WHO"},{"key":"S0950268807009211_ref009","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.6.694"},{"key":"S0950268807009211_ref005","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.320.7238.846"}],"container-title":["Epidemiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0950268807009211","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T16:11:39Z","timestamp":1587831099000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0950268807009211\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,3]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0950268807009211"],"URL":"https:\/\/doi.org\/10.1017\/s0950268807009211","relation":{},"ISSN":["0950-2688","1469-4409"],"issn-type":[{"value":"0950-2688","type":"print"},{"value":"1469-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,3]]}}}